Roche Holding is a research-based healthcare group active in the discovery, development and manufacture of pharmaceuticals and diagnostic systems. The Company develops, produces and markets products and services for unmet medical needs. The Company's products and services cover various areas of the healthcare market from the emerging fields of predisposition screening and early detection to prevention, diagnosis, therapy and treatment monitoring. The Company maintains healthcare activities in the areas of pharmaceuticals and orthopaedics and focuses on the prevention, diagnosis, monitoring and treatment of diseases and on the promotion of general well-being.
Data provided by Mergent, Inc.
Powered by Interactive Data Managed Solutions
Data provided by Thomson Reuters, Inc.
| US Record Date | US Payable Date | Net DR Amount |
|---|---|---|
| Mar 06, 2008 | Apr 21, 2008 | 1.8941 |
| Mar 07, 2007 | Apr 20, 2007 | 1.1536 |
| Mar 01, 2006 | Apr 17, 2006 | 0.7910 |
| DR Symbol | RHHBY |
| CUSIP | 771195104 |
| DR Exchange | OTCQX |
| DR ISIN | US7711951043 |
| Ratio | 4:1 |
| Depositary | JPMC (Sponsored) |
| Effective Date | Dec 19, 2008 |
| Country | Switzerland |
| Industry | Pharma. & Biotech. |
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
Apr. 13 |
62.42 | 12,217,671 | 555,349 |
Mar. 13 |
58.60 | 11,901,734 | 595,087 |
Feb. 13 |
57.37 | 8,386,862 | 441,414 |
This DR is a Constituent of the following BNY Mellon DR Indices:
|
Related links |
Helpful Links |